Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
9
90%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Completed6
Withdrawn2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (10.0%)
N/A9 (90.0%)

Trials by Status

completed660%
withdrawn220%
unknown110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10